These data suggest that CTNNB1 mutation supports the maintenance of a liver metabolic-like phenotype in HCC, while TP53-mutant tumors are more de-differentiated and highly proliferative (Supplementary Figure S3). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.